Compare AXR & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXR | STIM |
|---|---|---|
| Founded | 1961 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.3M | 120.4M |
| IPO Year | 2010 | 2018 |
| Metric | AXR | STIM |
|---|---|---|
| Price | $21.13 | $1.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 5.3K | ★ 1.6M |
| Earning Date | 12-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | ★ 0.05 | N/A |
| Revenue | $12,831,000.00 | ★ $52,776,000.00 |
| Revenue This Year | N/A | $8.63 |
| Revenue Next Year | $27.27 | $9.24 |
| P/E Ratio | $428.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.61 | $0.80 |
| 52 Week High | $29.01 | $3.44 |
| Indicator | AXR | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 31.21 |
| Support Level | $20.33 | $1.13 |
| Resistance Level | $21.55 | $1.61 |
| Average True Range (ATR) | 0.53 | 0.27 |
| MACD | 0.13 | -0.06 |
| Stochastic Oscillator | 56.71 | 1.51 |
Amrep Corp is engaged in real estate business. The company develops both residential lots and sites for commercial and industrial use as demand warrants. It offers for sale both developed and undeveloped real property to its internal homebuilder as well as national, regional, and local homebuilders, commercial and industrial property developers and others. Activities conducted or arranged by the company include land and site planning, obtaining governmental and environmental approvals, installing utilities and storm drains, ensuring the availability of water service, building or improving roads necessary for land development and constructing community amenities. It also provides landscaping services to homebuilders. It operates in two business segments: land development and homebuilding.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.